Compass Financial Management LLC Invests $1.17 Million in Cigna Group $CI

Compass Financial Management LLC purchased a new position in shares of Cigna Group (NYSE:CI) during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 4,254 shares of the health services provider’s stock, valued at approximately $1,173,000.

Other large investors also recently bought and sold shares of the company. Wilkerson Advisory Group LLC purchased a new stake in shares of Cigna Group in the fourth quarter valued at approximately $25,000. Kemnay Advisory Services Inc. acquired a new stake in shares of Cigna Group in the fourth quarter valued at approximately $29,000. Prosperity Bancshares Inc purchased a new position in Cigna Group during the fourth quarter worth approximately $29,000. Johnson Financial Group Inc. purchased a new position in Cigna Group during the second quarter worth approximately $29,000. Finally, Cedar Mountain Advisors LLC boosted its stake in Cigna Group by 161.9% during the first quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider’s stock worth $29,000 after buying an additional 68 shares during the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Cigna Group Price Performance

CI stock opened at $276.19 on Monday. Cigna Group has a 52-week low of $239.51 and a 52-week high of $315.47. The company has a quick ratio of 0.76, a current ratio of 0.76 and a debt-to-equity ratio of 0.68. The stock has a market cap of $72.98 billion, a price-to-earnings ratio of 11.43, a price-to-earnings-growth ratio of 0.95 and a beta of 0.29. The business has a fifty day moving average of $284.20 and a two-hundred day moving average of $281.45.

Cigna Group (NYSE:CI) last announced its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 EPS for the quarter, beating the consensus estimate of $7.60 by $0.18. The business had revenue of $70.04 billion for the quarter, compared to analyst estimates of $70.14 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.The company’s quarterly revenue was up 6.7% on a year-over-year basis. During the same quarter in the prior year, the company posted $7.20 EPS. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, research analysts anticipate that Cigna Group will post 30.51 earnings per share for the current year.

Cigna Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th will be given a $1.56 dividend. The ex-dividend date of this dividend is Tuesday, September 8th. This represents a $6.24 dividend on an annualized basis and a yield of 2.3%. Cigna Group’s dividend payout ratio is presently 25.82%.

Insider Transactions at Cigna Group

In other Cigna Group news, insider Nicole S. Jones sold 19,436 shares of the stock in a transaction dated Tuesday, August 4th. The shares were sold at an average price of $276.27, for a total transaction of $5,369,583.72. Following the completion of the transaction, the insider owned 27,256 shares of the company’s stock, valued at $7,530,015.12. This trade represents a 41.63% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of Cigna Group stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $298.61, for a total transaction of $268,450.39. Following the sale, the chief accounting officer owned 2,368 shares of the company’s stock, valued at approximately $707,108.48. This represents a 27.52% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 23,012 shares of company stock worth $6,386,550 in the last ninety days. 0.60% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

Several brokerages have issued reports on CI. Wolfe Research restated an “outperform” rating and issued a $315.00 target price on shares of Cigna Group in a report on Tuesday, June 16th. Morgan Stanley boosted their price target on shares of Cigna Group from $355.00 to $361.00 and gave the company an “overweight” rating in a research report on Wednesday, May 20th. Piper Sandler dropped their price objective on shares of Cigna Group from $370.00 to $346.00 and set an “overweight” rating for the company in a report on Wednesday, June 3rd. Deutsche Bank Aktiengesellschaft cut shares of Cigna Group from a “buy” rating to a “hold” rating and cut their price objective for the stock from $303.00 to $302.00 in a research report on Wednesday, May 20th. Finally, Robert W. Baird set a $362.00 target price on shares of Cigna Group in a research note on Friday, July 31st. Fifteen research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $339.45.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.